Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Craig

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Journal of the American Heart Association|May 17, 2024
Comprehensive Cardiovascular Risk Factor Control With a Mobile Health Cardiovascular Risk Self-Management ProgramEdo Paz, Vedant S Pargaonkar, Brian J Roach, et al.
Trials|October 25, 2016
A randomised controlled trial of the clinical and cost-effectiveness of a contingency management intervention compared to treatment as usual for reduction of cannabis use and of relapse in early psychosis (CIRCLE): a study protocol for a randomised controlled trialSonia Johnson, Luke Sheridan Rains, Steven Marwaha, et al.
The Lancet. Psychiatry|September 12, 2015
Clinical effectiveness of a staff training intervention in mental health inpatient rehabilitation units designed to increase patients' engagement in activities (the Rehabilitation Effectiveness for Activities for Life [REAL] study): single-blind, cluster-randomised controlled trialHelen Killaspy, Louise Marston, Nicholas Green, et al.
Psychology and Psychotherapy|December 7, 2025
Relational work with distressing voices mirroring experiences of discrimination and marginalisation: Three illustrative cases of an extended form of AVATAR therapy (AV-EXT)Thomas Ward, Hannah Ball, Alice Montague, et al.
ACS Synthetic Biology|September 8, 2017
Leaf LIMS: A Flexible Laboratory Information Management System with a Synthetic Biology FocusThomas Craig, Richard Holland, Rosalinda D'Amore, et al.
Health Technology Assessment (Winchester, England)|August 29, 2019
A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCTSonia Johnson, Luke Sheridan Rains, Steven Marwaha, et al.
Veterinary Parasitology, Regional Studies and Reports|April 25, 2019
Filarial dermatitis caused by Filaria taxideae in domestic ferrets (Mustela putorius furo) from the western United StatesLauren M Mulreany, Kevin D Niedringhaus, Heather M A Fenton, et al.
Trials|November 29, 2024
Correction: Optimising AVATAR therapy for people who hear distressing voices: study protocol for the AVATAR2 multi-centre randomised controlled trialPhilippa Garety, Clementine J Edwards, Thomas Ward, et al.
Blood Advances|March 2, 2021
A BCMAxCD3 bispecific T cell-engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cellsDavid J DiLillo, Kara Olson, Katja Mohrs, et al.
Trials|May 26, 2021
Optimising AVATAR therapy for people who hear distressing voices: study protocol for the AVATAR2 multi-centre randomised controlled trialPhilippa Garety, Clementine J Edwards, Thomas Ward, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Journal of the American Heart Association|May 17, 2024
Comprehensive Cardiovascular Risk Factor Control With a Mobile Health Cardiovascular Risk Self-Management ProgramEdo Paz, Vedant S Pargaonkar, Brian J Roach, et al.
Trials|October 25, 2016
A randomised controlled trial of the clinical and cost-effectiveness of a contingency management intervention compared to treatment as usual for reduction of cannabis use and of relapse in early psychosis (CIRCLE): a study protocol for a randomised controlled trialSonia Johnson, Luke Sheridan Rains, Steven Marwaha, et al.
The Lancet. Psychiatry|September 12, 2015
Clinical effectiveness of a staff training intervention in mental health inpatient rehabilitation units designed to increase patients' engagement in activities (the Rehabilitation Effectiveness for Activities for Life [REAL] study): single-blind, cluster-randomised controlled trialHelen Killaspy, Louise Marston, Nicholas Green, et al.
Psychology and Psychotherapy|December 7, 2025
Relational work with distressing voices mirroring experiences of discrimination and marginalisation: Three illustrative cases of an extended form of AVATAR therapy (AV-EXT)Thomas Ward, Hannah Ball, Alice Montague, et al.
ACS Synthetic Biology|September 8, 2017
Leaf LIMS: A Flexible Laboratory Information Management System with a Synthetic Biology FocusThomas Craig, Richard Holland, Rosalinda D'Amore, et al.
Health Technology Assessment (Winchester, England)|August 29, 2019
A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCTSonia Johnson, Luke Sheridan Rains, Steven Marwaha, et al.
Veterinary Parasitology, Regional Studies and Reports|April 25, 2019
Filarial dermatitis caused by Filaria taxideae in domestic ferrets (Mustela putorius furo) from the western United StatesLauren M Mulreany, Kevin D Niedringhaus, Heather M A Fenton, et al.
Trials|November 29, 2024
Correction: Optimising AVATAR therapy for people who hear distressing voices: study protocol for the AVATAR2 multi-centre randomised controlled trialPhilippa Garety, Clementine J Edwards, Thomas Ward, et al.
Blood Advances|March 2, 2021
A BCMAxCD3 bispecific T cell-engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cellsDavid J DiLillo, Kara Olson, Katja Mohrs, et al.
Trials|May 26, 2021
Optimising AVATAR therapy for people who hear distressing voices: study protocol for the AVATAR2 multi-centre randomised controlled trialPhilippa Garety, Clementine J Edwards, Thomas Ward, et al.
Pageof 9